Hemophilia Market Research Report and Trends Forecasts 2017 to 2021 Hemophilia Market Global Analysis 2017 | Página 2

Hemophilia Market - Global Industry Analysis, Size, Share, Growth, Trends
and Forecasts 2017 – 2021
Hemophilia Market has entered into an era of unprecedented growth rate with a variety of treatment
options. Development of new therapeutics along with expansion in the current treatment options has
presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder
causes abnormal bleeding with poor clotting. It is classified into hemophilia A, hemophilia B, hemophilia C,
and hemophilia with inhibitors.
Company Coverage of Global Hemophilia Market: Pfizer Inc., Bayer Group, Shire PLC, and Novo Nordisk.
Hemophilia Market include increased focus on prophylactic treatment, growing market for FVIII, increasing
diagnosis rate, and increasing healthcare expenditure. Major trends of the market include development of
novel hemophilia treatment, subcutaneous dosing and growing popularity of gene therapy. Further, growth
prospects are hindered by high cost of therapy and consumer’s reluctance in switching to new therapy
options.
Complete report available at http://www.marketreportsonline.com/579011.html